Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 261,700 | 55,300 | 76,800 | 23,600 | 68,600 |
| Receivables | 417,700 | 530,000 | 656,500 | 591,800 | 559,700 |
| Inventories | 327,600 | 569,400 | 520,000 | 474,600 | 424,700 |
| Income taxes - deferred | 41,300 | 42,600 | 7,100 | 9,200 | 14,200 |
| Other current assets | 92,700 | 19,400 | 15,700 | 54,200 | 39,400 |
| TOTAL | $1,141,000 | $1,216,700 | $1,276,100 | $1,153,400 | $1,106,600 |
| Non-Current Assets | |||||
| PPE Net | 1,113,600 | 1,116,300 | 1,050,000 | 998,500 | 1,075,500 |
| Investments And Advances | 21,500 | 22,100 | 23,800 | 23,300 | 20,300 |
| Intangibles | 1,101,400 | 1,124,500 | 1,589,300 | 1,528,600 | 1,503,700 |
| Other Non-Current Assets | 181,900 | 160,400 | 122,500 | 126,700 | 153,000 |
| TOTAL | $2,418,400 | $2,423,300 | $2,785,600 | $2,677,100 | $2,752,500 |
| Total Assets | $3,559,400 | $3,640,000 | $4,061,700 | $3,830,500 | $3,859,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 27,100 | 42,400 | 143,400 | 43,200 | 85,500 |
| Accounts payable and accrued liabilities | 272,200 | 249,400 | 316,500 | 298,800 | 278,600 |
| Accrued Expenses | 195,200 | 190,200 | 204,400 | 203,800 | 218,300 |
| Other current liabilities | 56,500 | N/A | N/A | 16,300 | N/A |
| TOTAL | $575,400 | $496,900 | $686,900 | $603,400 | $628,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 658,400 | 806,400 | 705,300 | 900,400 | 1,225,500 |
| Other Non-Current Liabilities | 696,900 | 734,600 | 619,800 | 644,700 | 656,900 |
| TOTAL | $1,420,900 | $1,664,300 | $1,460,800 | $1,650,400 | $1,992,400 |
| Total Liabilities | $1,996,300 | $2,161,200 | $2,147,700 | $2,253,800 | $2,621,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 97,551 | 94,309 | 95,299 | 95,635 | 92,786 |
| Common Shares | 500 | 500 | 500 | 500 | 500 |
| Retained earnings | 1,123,200 | 1,133,500 | 1,356,600 | 1,169,100 | 1,149,700 |
| Other shareholders' equity | 20,400 | -35,300 | 157,900 | -5,900 | -89,700 |
| TOTAL | $1,563,100 | $1,478,800 | $1,914,000 | $1,576,700 | $1,238,100 |
| Total Liabilities And Equity | $3,559,400 | $3,640,000 | $4,061,700 | $3,830,500 | $3,859,100 |